Fly News Breaks for February 22, 2016
CMRX
Feb 22, 2016 | 14:55 EDT
William Blair analyst Katherine Xu lowered Market Perfrom rated Cimerix's price target to $8 based on the strategic decision to terminate the SUPASS and SUSTAIN trials.
News For CMRX From the Last 2 Days
There are no results for your query CMRX